ライフサイエンスコーパス: standardized mortality ratio

1 patients when using the customized hospital standardized mortality ratio.

2 specially when using the customized hospital standardized mortality ratio.

3 the ICU scoring system used to calculate the standardized mortality ratio.

4 per year; self-reported health outcomes; and standardized mortality ratio.

5 or patients' severity and the ICU's baseline standardized mortality ratio.

6 mpared with the general population using the standardized mortality ratio.

7 and both a high absolute mortality and high standardized mortality ratio.

8 oved model accuracy but had little impact on standardized mortality ratios.

9 but did not substantially change unit-level standardized mortality ratios.

10 e Poisson regression models and by comparing standardized mortality ratios.

11 tatistic (where p>.05 suggests good fit) and standardized mortality ratios.

12 Quality-of-care tests were performed using standardized mortality ratios.

13 e the variability in subarachnoid hemorrhage standardized mortality ratios.

14 lity using the Kaplan-Meier method and using standardized mortality ratios.

15 zed morbidity ratios were more variable than standardized mortality ratios.

16 I, 0.86-1.03) during years 1991-1995 to 29% (standardized mortality ratio 0.53; 95% CI, 0.50-0.57) du

17 .8%-5.0%; p = 0.009), decreasing from 46.9% (standardized mortality ratio 0.94; 95% CI, 0.86-1.03) du

18 superior to that of the customized hospital standardized mortality ratio (0.85 and 0.11 vs. 0.77 and

19 not indicate any excess mortality (all-cause standardized mortality ratios = 0.69 and 0.64, respectiv

20 ects exposed and nonexposed to formaldehyde (standardized mortality ratios = 0.91 and 0.78, respectiv

21 that in the population of England and Wales (standardized mortality ratio, 0.46; 95% CI, 0.42, 0.51).

22 nificantly overestimated hospital mortality (standardized mortality ratio, 0.73 [confidence interval,

23 e direct causes (area under the curve, 0.81; standardized mortality ratio, 0.73; 95% CI, 0.31-1.43),

24 indirect causes (area under the curve, 0.89; standardized mortality ratio, 0.85; 95% CI, 0.59-1.19).

25 ospitalizations (area under the curve, 0.86; standardized mortality ratio, 0.96; 95% CI, 0.74-1.22),

26 mple that was based on U.S. population data (standardized mortality ratio, 0.98 [CI, 0.44 to 2.2]; P

27 r risk of homicide, suicide, and poisonings (standardized mortality ratios, 0.31-0.68), but higher ri

28 y than expected from the general population (standardized mortality ratio: 0.67; 95% CI: 0.55 to 0.78

29 tanding, mortality: 2.1% vs 2.8%, p < 0.001; standardized mortality ratio: 0.77 [0.73-0.82] vs 0.99 [

30 models, respectively), and good calibration (standardized mortality ratio: 0.99, 0.99, and 1.00; Hosm

31 on of actual vs. expected mortality, overall standardized mortality ratio (1.018; 95% confidence inte

32 t (observed mortality = predicted mortality; standardized mortality ratio = 1.000) and repeated with

33 ce interval (CI) 1.56-2.55) and lung cancer (standardized mortality ratio = 1.29, 95% CI 1.01-1.61).

34 of 21.7%; the observed mortality was 36.2% (standardized mortality ratio = 1.67).

35 rval (CI): 2.30, 5.56) and in the US cohort (standardized mortality ratio = 1.91, 95% CI: 1.02, 3.27)

36 ), and >10-year and >20-year mortality (both standardized mortality ratios ~1.5) than the general pop

37 handgun was greater than expected for women (standardized mortality ratio, 1.09), and the entire incr

38 orrhagic causes (area under the curve, 0.75; standardized mortality ratio, 1.0; 95% CI, 0.61-1.54).

39 t event-free survival for 24 months (pEFS24; standardized mortality ratio, 1.27; P < .001).

40 xpected survival for the general population (standardized mortality ratio, 1.34; 95% CI, 1.003-1.76;

41 oup did not differ from the population norm (standardized mortality ratio, 1.75; 95 percent confidenc

42 al population (78%; 95% CI, 76 to 80; v 87%; standardized mortality ratio, 1.75; P < .001).

43 xpected rate in the general U.S. population (standardized mortality ratio, 1.90; 95 percent confidenc

44 duals with CHDs had higher infant mortality (standardized mortality ratio=10.17), >1-year mortality (

45 the general population of England and Wales (standardized mortality ratio, 11.65; 95% confidence inte

46 the excess risk among women in this cohort (standardized mortality ratio, 15.50) remained greater th

47 ess mortality from silicosis/pneumoconioses (standardized mortality ratio = 18.2, 95% confidence inte

48 the risk of completed suicide is increased (standardized mortality ratio 2-3.5); although the causes

49 tion, cancer mortality was elevated overall (standardized mortality ratio 2.33; 95% confidence interv

50 or nonmalignant respiratory diseases (NMRD) (standardized mortality ratio = 2.01, 95% confidence inte

51 ignificantly elevated at 15 years after HCT (standardized mortality ratio = 2.2).

52 in the two groups (22.3% vs 20.2%; p = 0.40; standardized mortality ratio, 2.5 [2.1-3.0] vs 2.3 [1.9-

53 aled nitric oxide; 25.7% vs 7.9%; p < 0.001; standardized mortality ratio, 2.6 [2.3-3.1] vs 1.1 [1.0-

54 nilateral WT survivors, 142 deaths occurred (standardized mortality ratio, 2.9, 95% CI, 2.5 to 3.5; 3

55 psy had significantly higher mortality rate (Standardized mortality ratio: 2.39, 1.97-2.86).

56 cidents were observed in the Vietnam cohort (standardized mortality ratio = 3.67, 95% confidence inte

57 15.50) remained greater than that among men (standardized mortality ratio, 3.23).

58 times higher than in the general population (standardized mortality ratio, 3.92; 95% confidence inter

59 d mortality ratio=10.17), >1-year mortality (standardized mortality ratio=3.29), and >10-year and >20

60 rdiac death was 4-fold higher than expected (standardized mortality ratio, 4.2; 95% CI, 2.9-5.8).

61 cide by any method among handgun purchasers (standardized mortality ratio, 4.31) was attributable ent

62 Pneumonia (standardized mortality ratio 6.6, 95% confidence inciden

63 ts, falls, fires, and, especially, drowning (standardized mortality ratio=6.22).

64 to an excess risk of suicide with a firearm (standardized mortality ratio, 7.12).

65 The standardized mortality ratio (95% CI) was 4.97 (3.72-6.6

66 Cancer standardized incidence ratios and standardized mortality ratios (95% confidence intervals)

67 1 to 0.7]), comparable to the US population (standardized mortality ratio [95% CI]: 90sSR, 1.3 [0.8 t

68 Standardized mortality ratios, absolute excess risks, an

69 As a result of changing mortality risk, the standardized mortality ratios across the 16 pediatric IC

70 Standardized mortality ratios adjusted for severity-of-i

71 Standardized mortality ratios also showed excess mortali

72 andom slope hierarchical model, variation in standardized mortality ratio among intensive care units

73 ive care units varied from 0.62 to 1.27; the standardized mortality ratio and 95% confidence interval

74 The hospital standardized mortality ratio and Simplified Acute Physio

75 ich can be used to make inferences about the standardized mortality ratio and the standardized incide

76 mortality based on 95% interval estimates of standardized mortality ratios and (2) differences in ris

77 Standardized mortality ratios and 95% confidence interva

78 Standardized mortality ratios and absolute excess risks

79 Similar patterns were observed for both standardized mortality ratios and absolute excess risks

80 We also compared hospitals' standardized mortality ratios and classification of hosp

81 Standardized mortality ratios and relative risks were ca

82 hierarchical regression to calculate 30-day standardized mortality ratios and risk-standardized mort

83 on administrative data (customized hospital standardized mortality ratio) and a model based on clini

84 similar military service history, all-cause standardized mortality ratio, and age of death compared

85 Mortality rates, standardized mortality ratios, and 95% confidence interv

86 Cumulative incidence, standardized mortality ratios, and standardized incidenc

87 with mortality rates for White US men using standardized mortality ratios, and the death rates for m

88 2.20; at six years, 2.01) but low among men (standardized mortality ratio at one year, 0.84; at six y

89 ide with a firearm was elevated among women (standardized mortality ratio at one year, 2.20; at six y

90 chanical ventilation had the most discordant standardized mortality ratios between the two predictive

91 Intensive care unit standardized mortality ratios calculated with MPM0-III a

92 Comparing institutions based on standardized mortality ratios can be unfavorable for tho

93 Standardized mortality ratios compared infant mortality,

94 port crude and standardised mortality rates, standardized mortality ratios comparing mortality experi

95 Standardized mortality ratios comparing the Crit-Line an

96 The VA ICU standardized mortality ratio correlates with the Nationa

97 days in 1994-96 to 2.4 per 1,000 in 2003-06; standardized mortality ratio decreased from 0.33 to 0.27

98 s, and how case-mix adjustment might explain standardized mortality ratio differences.

99 ter having a widely dispersed and multimodal standardized mortality ratio distribution.

100 The standardized mortality ratios divided observed deaths by

101 Two ICUs had standardized mortality ratios exceeding 1.75 using Natio

102 The standardized mortality ratio for all causes of death was

103 During 1998-2008, the standardized mortality ratio for CRC in individuals with

104 The standardized mortality ratio for ischaemic heart disease

105 For white miners, the standardized mortality ratio for lung cancer compared wi

106 The standardized mortality ratio for patients with recurrent

107 The standardized mortality ratio for suicide during pregnanc

108 ted World Health Organization suicide rates (Standardized Mortality Ratio for suicide: SMR 12.63-15.6

109 However, although the standardized mortality ratio for the entire cohort was h

110 Among the various subgroups, the standardized mortality ratio for the patients on dialysi

111 The standardized mortality ratio for the Quebec cohort as co

112 The original standardized mortality ratio for the silica-lung cancer

113 The overall standardized mortality ratio for those with definite or

114 For all cancers combined, the standardized mortality ratios for all cardiac diseases c

115 Standardized mortality ratios for all-cause mortality in

116 Standardized mortality ratios for all-cause mortality we

117 Estimated 15-year survival and standardized mortality ratios for deaths from nonneoplas

118 We assessed standardized mortality ratios for each ICU using data fo

119 Standardized mortality ratios for each ICU were calculat

120 We calculated standardized mortality ratios for each trial from observ

121 Standardized mortality ratios for kidney disease were co

122 eas were excessive, especially among blacks (standardized mortality ratios for men and women in Harle

123 were calculated using 5-year age groups and standardized mortality ratios for PEH and the general po

124 compared with age-adjusted and race-adjusted standardized mortality ratios for women, which were calc

125 djusted mortality was noted by a decrease of standardized mortality ratio from 10.0 (95% confidence i

126 There were modest changes in an ICU's standardized mortality ratio grouping (< 1.00, not signi

127 These standardized mortality ratios have not declined substant

128 1.17 (95%CI [0.85, 1.62]), and the weighted standardized mortality ratio in cohort studies was 98 (9

129 Score II outperforms the customized hospital standardized mortality ratio in the Dutch intensive care

130 se who were alive at 20 years follow-up, the standardized mortality ratio in the subsequent years rem

131 s had influence on the intensive care units' standardized mortality ratios in both models, but the cu

132 Age and sex standardized mortality ratios measured the associations

133 ost similar to that of whites and the lowest standardized mortality ratio (men, 1.18; women, 1.08).

134 whites were studied, Detroit had the highest standardized mortality ratios (men, 2.01; women, 1.90).

135 ease (28%) and cancer (28%), with respective standardized mortality ratios nearly six-fold (5.81; 95%

136 Standardized mortality ratio (observed/expected deaths)

137 statistic and calibration as assessed by the standardized mortality ratio (observed:expected mortalit

138 as calculated to estimate the reliability of standardized mortality ratios obtained using the three r

139 ty of 8.93% (Student t test, p = 0.52) and a standardized mortality ratio of 0.98 (0.932-1.034).

140 7331 (13.2%) vs. 7456 predicted, yielding a standardized mortality ratio of 0.983, 95% CI (0.963-1.0

141 e confounding by smoking, led to an adjusted standardized mortality ratio of 1.43 (95% Monte Carlo li

142 olamban R14del mutation carriers, we found a standardized mortality ratio of 1.7 (95% confidence inte

143 nity-based cohort (p< 0.001), resulting in a standardized mortality ratio of 3.49 (95% CI, 2.42-4.85)

144 first 10 years of follow-up, resulting in a standardized mortality ratio of 7.7 (95% CI=3.7-14.2).

145 ng a conditional approach and expressed as a standardized mortality ratio of observed-to-expected dea

146 Standardized mortality ratio of the intensive care units

147 ortality than the reference population, with standardized mortality ratios of 1.5 to 2.5.

148 an did women in the general population, with standardized mortality ratios of 2.15 (ages 40-49 years)

149 Standardized mortality ratios of all causes and specific

150 agreed on the significance and direction of standardized mortality ratio only 45% of the time.

151 demographic distribution would increase the standardized mortality ratio only modestly to 54 for wom

152 articles have shown how to translate from a standardized mortality ratio or hazard ratio to a longev

153 for each unit using a hierarchical logistic (standardized mortality ratio) or linear (OMELOS) regress

154 PM0-III identifying 33 of 135 as significant standardized mortality ratio outliers and the subgroup m

155 nal Surgical Quality Improvement Performance standardized mortality ratio (r2 = .74).

156 s relative to men in the general population; standardized mortality ratios ranged from 2.56 (ages 30-

157 Standardized mortality ratios relative to the US populat

158 Mortality estimates (eg, standardized mortality ratios, relative risks, hazard ra

159 Four ICUs had standardized mortality ratios significantly less than 1.

160 Quarterly estimates of CMI and standardized mortality ratio (SMR) (observed-to-expected

161 atistic (range, 10.6-15.3; p > or = .05) and standardized mortality ratio (SMR) (range, 0.93 [95% con

162 increased brain cancer in the entire cohort (standardized mortality ratio (SMR) = 0.9, 95% confidence

163 terans was not different from that expected (standardized mortality ratio (SMR) = 1.0).

164 All cancers combined (standardized mortality ratio (SMR) = 1.0, 95% confidence

165 for carriers diagnosed before age 15 years (standardized mortality ratio (SMR) = 2.00, 95% confidenc

166 fic mortality was elevated for mesothelioma (standardized mortality ratio (SMR) = 2.85, 95% confidenc

167 ased risk of mortality from liver cirrhosis (standardized mortality ratio (SMR) = 8.4, 95% CI 3.1-18.

168 ratio assumption is established between the standardized mortality ratio (SMR) and the life expectan

169 ears; standardized incidence ratio (SIR) and standardized mortality ratio (SMR) compared with those e

170 We calculated the standardized mortality ratio (SMR) for COVID-19 comparin

171 pared to patients without this exposure; and standardized mortality ratio (SMR) for suicide post-surg

172 y rate is 10.61/10,000-person years, and the standardized mortality ratio (SMR) of fatal heart diseas

173 was 21.64 per 100,000-person years, and the standardized mortality ratio (SMR) of fatal stroke was 2

174 ide was 28.58/ 100,000-person years, and the standardized mortality ratio (SMR) of suicide was 4.44 (

175 The standardized mortality ratio (SMR) was 0.90 for all caus

176 A center-level standardized mortality ratio (SMR) was constructed (rati

177 ected mortality in the general population, a standardized mortality ratio (SMR) was used.

178 ing on prespecified prognostic factors using standardized mortality ratio (SMR) weighting.

179 comparison with the general population, the standardized mortality ratio (SMR), adjusted for age and

180 ported a standardized incidence ratio (SIR), standardized mortality ratio (SMR), or data on expected

181 inverse probability of treatment weighting, standardized mortality ratio (SMR)-treated, SMR-untreate

182 ith the person-years method to determine the standardized mortality ratio (SMR).

183 nit (ICU) length of stay, ICU mortality, and standardized mortality ratio (SMR).

184 rtality and short-term performance by 90-day standardized mortality ratio (SMR; observed/expected mor

185 HL had worse-than-expected OS as measured by standardized mortality ratio (SMR; SMR for CLL, 2.6; 95%

186 We estimated standardized mortality ratios (SMR) and used competing r

187 ta, we simulated report cards and calculated standardized mortality ratios (SMR) for kidney transplan

188 and clinical relevance of TTNtv by analyzing standardized mortality ratios (SMR) in multigenerational

189 Kaplan-Meier survival estimates, standardized mortality ratios (SMR), and standard incide

190 th patients unexposed to immunosuppressants (standardized mortality ratio [SMR] = 0.95, 95% confidenc

191 at a 13-fold increased risk for late death (standardized mortality ratio [SMR] = 13.0) when compared

192 ients with cancers of the lung and bronchus (standardized mortality ratio [SMR] = 5.74; 95% CI, 5.30

193 The expected number of deaths was 87 (standardized mortality ratio [SMR]), 1.9; 95% confidence

194 ortality ratio method (main outcome measure, standardized mortality ratio [SMR]).

195 0.915-0.921) and calibration was excellent (standardized mortality ratio [SMR], 0.986; 95% CI, 0.966

196 the age- and sex-matched general population (standardized mortality ratio [SMR], 1.18; P = .25).

197 sk of BC mortality was also greater for men (standardized mortality ratio [SMR], 1.32 [95% CI, 1.18-1

198 increased compared with expected mortality (standardized mortality ratio [SMR], 2.6 [95% CI, 1.8-3.7

199 ection (30-year cumulative incidence, 10.7%; standardized mortality ratio [SMR], 52.0), subsequent ma

200 tality attributable to subsequent neoplasms (standardized mortality ratios [SMR], 15.2; 95% CI, 13.9

201 Standardized incidence ratios (SIRs) and standardized mortality ratios (SMRs) (observed/expected

202 h were used to estimate late mortality using standardized mortality ratios (SMRs) and 95% CIs, which

203 Standardized mortality ratios (SMRs) and 95% confidence

204 ional reference rates were used to calculate standardized mortality ratios (SMRs) and 95% confidence

205 Comparative standardized mortality ratios (SMRs) and causes of death

206 Standardized mortality ratios (SMRs) and Cox regression

207 e analysis and assessed mortality risk using standardized mortality ratios (SMRs) and marginal struct

208 registries in New York City, they calculated standardized mortality ratios (SMRs) and relative risks.

209 Standardized mortality ratios (SMRs) and standardized in

210 Standardized mortality ratios (SMRs) based on deaths thr

211 Standardized mortality ratios (SMRs) compared rates of p

212 orth Carolina and Iowa, the authors computed standardized mortality ratios (SMRs) comparing deaths fr

213 Standardized mortality ratios (SMRs) for CVD and absolut

214 Standardized mortality ratios (SMRs) for different cause

215 Standardized mortality ratios (SMRs) for non-diabetes-re

216 Standardized mortality ratios (SMRs) for overall mortali

217 Standardized incidence ratios (SIRs) and standardized mortality ratios (SMRs) of CRC after high-

218 Standardized incidence ratios (SIRs) and standardized mortality ratios (SMRs) of ischemic heart d

219 Standardized mortality ratios (SMRs) of suicide deaths a

220 Standardized mortality ratios (SMRs) of suicide, assessi

221 Standardized mortality ratios (SMRs) reported by Medicar

222 We used standardized mortality ratios (SMRs) to compare cause-sp

223 Standardized mortality ratios (SMRs) were calculated adj

224 Standardized mortality ratios (SMRs) were calculated for

225 Standardized mortality ratios (SMRs) were calculated for

226 Standardized mortality ratios (SMRs) were calculated for

227 Standardized incidence ratios (SIRs) and standardized mortality ratios (SMRs) were calculated for

228 Age and sex standardized mortality ratios (SMRs) were calculated usi

229 Standardized mortality ratios (SMRs) were calculated usi

230 Standardized mortality ratios (SMRs) were calculated, ba

231 Vital status and standardized mortality ratios (SMRs) were estimated at s

232 Significantly increased standardized mortality ratios (SMRs) were found for all

233 Standardized mortality ratios (SMRs) were used to assess

234 Age-standardized mortality ratios (SMRs) were used to compar

235 Poisson models provided standardized mortality ratios (SMRs) with 95% confidence

236 l were compared using the log-rank test, and standardized mortality ratios (SMRs) with expected survi

237 with the Norwegian Cause of Death Registry, standardized mortality ratios (SMRs), absolute excess ri

238 both U.S. Census data and death record data, standardized mortality ratios (SMRs), relative SMRs (rSM

239 Using standardized mortality ratios (SMRs), we compared cancer

240 where Antofagasta is located, and calculated standardized mortality ratios (SMRs).

241 rison and mortality records, they calculated standardized mortality ratios (SMRs).

242 9-affected SOTRs was analyzed by calculating standardized mortality ratios (SMRs).

243 d with similar individuals without MIS), and standardized mortality ratios (SMRs).

244 ed with that of the general population using standardized mortality ratios (SMRs).

245 ge, sex, calendar date, and country to yield standardized mortality ratios (SMRs).

246 as standardized incidence ratios (SIRs) and standardized mortality ratios (SMRs).

247 re younger than 75 years had higher coronary-standardized mortality ratios than men; for example, amo

248 including the two largest centers) had lower standardized mortality ratios than might be expected due

249 The standardized mortality ratio (the ratio of the number of

250 zing the effect on the intensive care units' standardized mortality ratios.The area under the receive

251 cause of death with a consistently elevated standardized mortality ratio throughout follow-up.

252 rity-adjusted mortality measures such as the standardized mortality ratio to benchmark their performa

253 We estimated a standardized mortality ratio to compare mortality in our

254 We calculated standardized mortality ratios to compare the causes of d

255 We used standardized mortality ratios to compare the groups of v

256 azard ratio or incidence density ratio, or a standardized mortality ratio, to measure a difference in

257 n of HAART, which demonstrated an increasing standardized mortality ratio trend after 1996.

258 Intensive care unit standardized mortality ratios, using the subgroup models

259 Standardized mortality ratios utilizing national US data

260 The standardized mortality ratio varied by duration of illne

261 Overall standardized mortality ratio was 0.89 using Acute Physio

262 Standardized mortality ratio was 1.16 (95% CI, 0.92 to 1

263 as 88.4% at 10 years after diagnosis and the standardized mortality ratio was 1.56 (95% confidence in

264 The lung cancer standardized mortality ratio was 1.60 (95% confidence in

265 For male patients, the age-adjusted standardized mortality ratio was 1.66; for females, it w

266 low-up of 6.27 years (141 liver deaths); the standardized mortality ratio was 2.85.

267 One-year age-standardized mortality ratio was 21-fold higher than exp

268 For American Indian miners, the lung cancer standardized mortality ratio was 3.27 (95% confidence in

269 The standardized mortality ratio was 4.0 (95% confidence int

270 The standardized mortality ratio was 4.37 (95% CI=2.4-7.3) f

271 The standardized mortality ratio was 4.83 (95% CI=2.91-8.01)

272 matched individuals was 83.5%, and estimated standardized mortality ratio was 69.9 (95% confidence in

273 The standardized mortality ratio was high for these causes i

274 Standardized mortality ratio was not associated with OME

275 Evaluation of ICU performance using standardized mortality ratio was only modestly sensitive

276 No standardized mortality ratio was significantly elevated

277 cases with predictions in both systems, the standardized mortality ratio was similar (1.04 for VA IC

278 quality outliers were defined as ICUs whose standardized mortality ratio was statistically different

279 hted-OR, 1.03 [95% CI, 1.02-1.05]; P < .001; standardized mortality ratio weighted-OR, 1.10 [95% CI,

280 95% confidence interval: 0.67, 1.84) for the standardized-mortality-ratio weighted to 10.77 (95% conf

281 We pooled data across trials and used standardized-mortality-ratio-weighted Cox proportional h

282 adjusted for using a propensity score-based standardized mortality ratio weighting method.

283 weights), another in the treated population (standardized-mortality-ratio weights).

284 ceiver operator characteristic curve and the standardized mortality ratio were 0.92 (confidence inter

285 The adjusted standardized mortality ratios were 0.44 (95 percent conf

286 Standardized mortality ratios were 12.2 (95% confidence

287 The standardized mortality ratios were 5.86 for AN, 1.93 for

288 Cause-specific standardized mortality ratios were 56 for cancer, 37 for

289 Standardized mortality ratios were 7.28 (95% CI: 6.50, 8

290 -adjusted rates of in-hospital mortality and standardized mortality ratios were calculated for four t

291 and cause-specific (cardiac disease, cancer) standardized mortality ratios were calculated.

292 ival probability after cancer diagnosis, and standardized mortality ratios were calculated.

293 Standardized mortality ratios were elevated for all caus

294 ng disorder not otherwise specified; suicide standardized mortality ratios were elevated for bulimia

295 The early standardized mortality ratios were high and decreased th

296 After adjustment for patient differences, standardized mortality ratios were significantly better

297 All-cause standardized mortality ratios were significantly elevate

298 Posttransplant survival and center's standardized mortality ratios were then calculated and c

299 ulation from 2014 to 2019 using age-specific standardized mortality ratios with 95% CIs.

300 Standardized mortality ratios with TAVR, SAVR, and conse